EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Rechallenge With Immune Checkpoint Inhibitors in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

M Ren, Y Wang, Z Xiang, H Ding, X Xia, Z Ding, J Xie, N Ding, Y Yang

Clinical Oncology · 2026-07 · 55 · 104180

DOI: 10.1016/j.clon.2026.104180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Oncology, 2026-07. Verfasst von M Ren und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Adenocarcinoma, Immune Checkpoint Inhibitors, Esophagogastric Junction. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsAdenocarcinomaImmune Checkpoint InhibitorsEsophagogastric JunctionEsophageal NeoplasmsHumansMaleFemaleAgedMiddle AgedAged, 80 and overAdultRetrospective Studies

Stichwörter der Autor:innen

Gastric/gastroesophageal junction adenocarcinomaimmune checkpoint blockersimmune checkpoint inhibitorsimmunotherapy

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China.
  • Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Electronic address: dingnq@126.com.
  • Department of Oncology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China. Electronic address: wing_young7@hotmail.com.

Zitieren

APA

Ren, M., Wang, Y., Xiang, Z., Ding, H., Xia, X., Ding, Z., Xie, J., Ding, N., & Yang, Y. (2026). Rechallenge With Immune Checkpoint Inhibitors in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. Clinical Oncology, 55, 104180. https://doi.org/10.1016/j.clon.2026.104180

Vancouver

Ren M, Wang Y, Xiang Z, Ding H, Xia X, Ding Z, et al. Rechallenge With Immune Checkpoint Inhibitors in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. Clinical Oncology. 2026;55:104180. doi:10.1016/j.clon.2026.104180

BibTeX
@article{Ren2026,
  author = {Ren, M and Wang, Y and Xiang, Z and Ding, H and Xia, X and Ding, Z and Xie, J and Ding, N and Yang, Y},
  title = {Rechallenge With Immune Checkpoint Inhibitors in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma},
  journal = {Clinical Oncology},
  year = {2026},
  volume = {55},
  pages = {104180},
  doi = {10.1016/j.clon.2026.104180}
}
Kostenlos starten →